Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-03-28Clinical Trial Update: Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD [NA]
A completed clinical trial investigating genetic polymorphism of cholesterol 24S-hydroxylase in patients with glaucoma and age-related macul…
-
CLINICAL_TRIALS trial_result · 2011-03-16Clinical Trial Update: Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ranibizumab for subfoveal choroidal neovascularization due to age-related macular degene…
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: Bevacizumab for Neovascular Age-related Macular Degeneration [NA]
This update notes the completion of a clinical trial evaluating bevacizumab for neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to …
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating verteporfin photodynamic therapy in combination with ranibizumab for subfoveal choroidal neovascularization due…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration
Pfizer-sponsored observational study evaluates long-term effects of Macugen (pegaptanib) in patients with wet age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration [Phase 3]
This update reports the completion and posted results of the Phase 3 SUSTAIN trial evaluating ranibizumab for subfoveal choroidal neovascula…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD [Phase 4]
Open-label Phase 4 trial of Macugen in subjects with neovascular age-related macular degeneration was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-11-18Clinical Trial Update: MP-1 Biofeedback: Pattern Stimulus Versus Audio-feedback in AMD [NA]
This completed trial compared MP-1 Biofeedback pattern stimulus to audio-feedback in age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: A Study Of Early Markers Of Choroidal Neovascularization
Pfizer-sponsored clinical trial investigating early markers of choroidal neovascularization in age-related macular degeneration has been ter…
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF [Phase 2]
Phase 2 trial evaluating safety and efficacy of ATG003 in age-related macular degeneration patients receiving anti-VEGF therapy has complete…
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Investigation of Macular Pigment Augmentation on Dark Adaptation [Phase 4]
A Phase 4 clinical trial investigating macular pigment augmentation on dark adaptation in aging and age-related macular degeneration was ter…
-
CLINICAL_TRIALS trial_result · 2010-09-23Clinical Trial Update: Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
This clinical trial update notes the completion of a beta telemedicine assessment study for age-related macular degeneration. The sponsor is…
-
CLINICAL_TRIALS trial_result · 2010-09-23Clinical Trial Update: Age-Related Macular Degeneration (AMD) - Usability Study
Completed usability study of an AMD-related intervention sponsored by Notal Vision Ltd.; evaluates usability in age-related macular degenera…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD [Phase 1]
Phase 1 safety evaluation of single and repeated intravitreal doses of JSM6427 for age-related macular degeneration has completed.
-
CLINICAL_TRIALS research · 2010-08-03Clinical Trial Update: Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration
This clinical trial update investigates the potential roles of CD35, CD21, and CD55 in exudative age-related macular degeneration. The curre…
-
CLINICAL_TRIALS trial_result · 2010-07-20Clinical Trial Update: Size Progression of Macular Degeneration After Cataract Surgery [Phase 4]
Phase 4 clinical trial update on the progression of age-related macular degeneration after cataract surgery; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) [Phase 2]
A Phase 2 RADICAL trial evaluated reduced fluence Visudyne in combination with an anti-VEGF agent and dexamethasone for choroidal neovascula…
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration [Phase 3]
The Manta Study is a Phase 3 trial comparing Avastin (bevacizumab) with Lucentis (ranibizumab) for age-related macular degeneration; the sta…
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: The Spectralis-Cirrus Study
The Spectralis-Cirrus Study evaluating imaging in exudative age-related macular degeneration has completed.
-
CLINICAL_TRIALS research · 2010-06-09Clinical Trial Update: Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD
A clinical trial update investigates posterior macular adhesion as a potential risk factor for progression from dry age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2010-05-27Clinical Trial Update: Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration [Phase 2]
Phase 2 clinical trial comparing triple therapy (PDT with verteporfin and intravitreal ranibizumab) to ranibizumab monotherapy for age-relat…
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD [Phase 2]
Open-label Phase 2 pilot study of TG100801 for choroidal neovascularization due to age-related macular degeneration has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration [Phase 2]
A Phase 2 study evaluating TAC-PF with Avastin and photodynamic therapy for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Complications of Age-Related Macular Degeneration Prevention Trial [Phase 3]
Phase 3 trial update indicating completion of a prevention trial for age-related macular degeneration; no efficacy results are provided in t…